Junshi, Coherus gun for major PD-(L)1 market with PhIII NSCLC results
As a slate of made-in-China checkpoint inhibitors arrive on the scene, China-based drugmakers have shown time and again that they’re not content with just the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
